BioCentury | Dec 14, 2018
Financial News

WuXi AppTec unchanged in first day of trading on Hong Kong exchange

...company at HK$79.2 billion ($10.1 billion). The listing is the third for a unit of New WuXi Life Science Ltd....
...Securities, China Renaissance, BOC International and CLSA. WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359), Shanghai, China Sandi Wong New WuXi Life Science Ltd. WuXi...
BioCentury | Dec 7, 2018
Financial News

WuXi AppTec prices Hong Kong offering in stormy market

...on its proposed number of shares. The listing is the third for a unit of New WuXi Life Science Ltd....
...Hong Kong), Goldman Sachs (Asia), UBS, China Merchants Securities, China Renaissance, BOC International and CLSA. Sandi Wong New WuXi Life Science Ltd. WuXi...
BioCentury | Oct 11, 2018
Strategy

Border security for China’s genomes

...and clinical diagnostics, Foundation Medicine has partnered with the WuXi NextCode Genomics Inc. subsidiary of New WuXi Life Science Ltd....
...Technology of the People’s Republic of China, Beijing, China National Medical Products Administration, Beijing, China New WuXi Life Science Ltd....
BioCentury | Sep 21, 2018
Finance

Funding WuXi’s expansion

...always useful.” Helen Chen, L.E.K. WuXi AppTec declined to provide comment. WuXi AppTec parent company New WuXi Life Science Ltd....
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...GeneBank, a bio-repository and -omics database. In 2015, CRO giant WuXi PharmaTech Inc. -- now New WuXi Life Science Ltd....
...Beijing, China National Institutes of Health, Bethesda, Md. National Medical Products Administration (NMPA), Beijing, China New WuXi Life Science Ltd....
BioCentury | Jun 2, 2018
Strategy

Partnering on a mission

...NextCode Health, which was acquired by WuXi Pharma Tech Inc. in 2015, now part of New WuXi Life Science Ltd....
BioCentury | May 11, 2018
Financial News

WuXi AppTec prices Shanghai IPO

...company began trading on May 8. WuXi AppTec has been operating as a unit of New WuXi Life Science Ltd....
...on the New York Stock Exchange (see BioCentury, Aug. 15, 2016) . Another company under New WuXi's...
BioCentury | May 7, 2018
Financial News

WuXi AppTec prices Shanghai IPO

...expects to begin trading on Tuesday. WuXi AppTec has been operating as a unit of New WuXi Life Science Ltd....
...on the New York Stock Exchange (see BioCentury, Aug. 15, 2016) . Another company under New WuXi's...
BioCentury | Apr 6, 2018
Finance

China’s exchange options

...of company the program hopes to attract. On March 27, the WuXi AppTec unit of New WuXi Life Science Ltd....
BioCentury | Apr 2, 2018
Finance

Maintaining Moderna

...by about tenfold.” Ji cited WuXi Biologics Inc. (HKSE:2269) and 3SBio Inc. (HKSE:1530) as examples. New WuXi Life Science Ltd....
Items per page:
1 - 10 of 72
BioCentury | Dec 14, 2018
Financial News

WuXi AppTec unchanged in first day of trading on Hong Kong exchange

...company at HK$79.2 billion ($10.1 billion). The listing is the third for a unit of New WuXi Life Science Ltd....
...Securities, China Renaissance, BOC International and CLSA. WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359), Shanghai, China Sandi Wong New WuXi Life Science Ltd. WuXi...
BioCentury | Dec 7, 2018
Financial News

WuXi AppTec prices Hong Kong offering in stormy market

...on its proposed number of shares. The listing is the third for a unit of New WuXi Life Science Ltd....
...Hong Kong), Goldman Sachs (Asia), UBS, China Merchants Securities, China Renaissance, BOC International and CLSA. Sandi Wong New WuXi Life Science Ltd. WuXi...
BioCentury | Oct 11, 2018
Strategy

Border security for China’s genomes

...and clinical diagnostics, Foundation Medicine has partnered with the WuXi NextCode Genomics Inc. subsidiary of New WuXi Life Science Ltd....
...Technology of the People’s Republic of China, Beijing, China National Medical Products Administration, Beijing, China New WuXi Life Science Ltd....
BioCentury | Sep 21, 2018
Finance

Funding WuXi’s expansion

...always useful.” Helen Chen, L.E.K. WuXi AppTec declined to provide comment. WuXi AppTec parent company New WuXi Life Science Ltd....
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...GeneBank, a bio-repository and -omics database. In 2015, CRO giant WuXi PharmaTech Inc. -- now New WuXi Life Science Ltd....
...Beijing, China National Institutes of Health, Bethesda, Md. National Medical Products Administration (NMPA), Beijing, China New WuXi Life Science Ltd....
BioCentury | Jun 2, 2018
Strategy

Partnering on a mission

...NextCode Health, which was acquired by WuXi Pharma Tech Inc. in 2015, now part of New WuXi Life Science Ltd....
BioCentury | May 11, 2018
Financial News

WuXi AppTec prices Shanghai IPO

...company began trading on May 8. WuXi AppTec has been operating as a unit of New WuXi Life Science Ltd....
...on the New York Stock Exchange (see BioCentury, Aug. 15, 2016) . Another company under New WuXi's...
BioCentury | May 7, 2018
Financial News

WuXi AppTec prices Shanghai IPO

...expects to begin trading on Tuesday. WuXi AppTec has been operating as a unit of New WuXi Life Science Ltd....
...on the New York Stock Exchange (see BioCentury, Aug. 15, 2016) . Another company under New WuXi's...
BioCentury | Apr 6, 2018
Finance

China’s exchange options

...of company the program hopes to attract. On March 27, the WuXi AppTec unit of New WuXi Life Science Ltd....
BioCentury | Apr 2, 2018
Finance

Maintaining Moderna

...by about tenfold.” Ji cited WuXi Biologics Inc. (HKSE:2269) and 3SBio Inc. (HKSE:1530) as examples. New WuXi Life Science Ltd....
Items per page:
1 - 10 of 72